Viewing StudyNCT04443907



Ignite Creation Date: 2024-05-06 @ 2:50 PM
Last Modification Date: 2024-10-26 @ 1:38 PM
Study NCT ID: NCT04443907
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-01-03
First Post: 2020-04-29

Brief Title: Study of Safety and Efficacy of Genome-edited Hematopoietic Stem and Progenitor Cells in Sickle Cell Disease SCD
Sponsor: Novartis Pharmaceuticals
Organization: Novartis

Conditions & Keywords Data

Conditions:
Name
Sickle Cell Disease
Keywords:
Name View
BCL11A View
Gene therapy View
genome-edited hematopoietic stem and progenitor cellular therapy View
sickle cell View
autologous transplant View